Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Bethesda, MD
SEC filing record 1 source field available
Fiscal year end
31 August
CNBX Pharmaceuticals Inc. has filed 300 SEC EDGAR filings since 09 Jan 2006

SEC filing history

Showing 226-250 of 265 matching filings.

Per page
25
Current page
10
8-K File 000-52403

CURRENT REPORT

Filing date
28 Jun 2013
Reporting date
24 Jun 2013
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-52403

QUARTERLY REPORT

Filing date
15 Apr 2013
Reporting date
28 Feb 2013
Next action
Verify source filing
10-Q File 000-52403

QUARTERLY REPORT

Filing date
14 Jan 2013
Reporting date
30 Nov 2012
Next action
Verify source filing
10-K File 000-52403

ANNUAL REPORT

Filing date
30 Nov 2012
Reporting date
31 Aug 2012
Next action
Verify source filing
NT 10-K File 000-52403

NOTICE OF LATE FILING

Filing date
29 Nov 2012
Reporting date
31 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52403

CURRENT REPORT

Filing date
28 Aug 2012
Reporting date
27 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52403

CURRENT REPORT

Filing date
27 Jul 2012
Reporting date
25 Jul 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-52403

QUARTERLY REPORT

Filing date
06 Jul 2012
Reporting date
31 May 2012
Next action
Verify source filing
8-K File 000-52403

CURRENT REPORT

Filing date
17 Apr 2012
Reporting date
14 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-52403

QUARTERLY REPORT

Filing date
13 Apr 2012
Reporting date
29 Feb 2012
Next action
Verify source filing
10-Q File 000-52403

QUARTERLY REPORT

Filing date
13 Jan 2012
Reporting date
30 Nov 2011
Next action
Verify source filing
10-K File 000-52403

ANNUAL REPORT

Filing date
29 Nov 2011
Reporting date
31 Aug 2011
Next action
Verify source filing
8-K/A File 000-52403

8-K/A filing

Filing date
17 Nov 2011
Reporting date
08 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Nov 2011
Reporting date
08 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52403

CURRENT REPORT

Filing date
14 Nov 2011
Reporting date
08 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52403

CURRENT REPORT

Filing date
14 Nov 2011
Reporting date
08 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52403

CURRENT REPORT

Filing date
07 Nov 2011
Reporting date
02 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-52403

QUARTERLY REPORT

Filing date
21 Jul 2011
Reporting date
31 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-52403

NOTIFICATION OF LATE FILING

Filing date
14 Jul 2011
Reporting date
31 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52403

CURRENT REPORT

Filing date
05 Jul 2011
Reporting date
01 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52403

CURRENT REPORT

Filing date
29 Jun 2011
Reporting date
27 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-83146

SCHEDULE 13D

Filing date
29 Jun 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
28 Jun 2011
Reporting date
31 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52403

CURRENT REPORT

Filing date
20 Jun 2011
Reporting date
17 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-52403

CURRENT REPORT

Filing date
07 Jun 2011
Reporting date
31 May 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .